• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于血清和尿液中游离免疫球蛋白轻链的高灵敏度自动化免疫测定法。

Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.

作者信息

Bradwell A R, Carr-Smith H D, Mead G P, Tang L X, Showell P J, Drayson M T, Drew R

机构信息

Department of Immunology, The Medical School, Edgbaston, Birmingham B15 2TT, United Kingdom.

出版信息

Clin Chem. 2001 Apr;47(4):673-80.

PMID:11274017
Abstract

BACKGROUND

Bence Jones proteins or monoclonal immunoglobulin kappa and lambda free light chains (FLCs) are important markers for identifying and monitoring many patients with B-cell tumors. Automated immunoassays that measure FLCs in urine and serum have considerable clinical potential.

METHODS

Sheep antibodies, specific for FLCs, were prepared by immunization with pure kappa and lambda molecules and then adsorbed extensively against whole immunoglobulins. The antibodies were conjugated onto latex particles and used to assay kappa and lambda FLCs on the Beckman IMMAGE protein analyzer.

RESULTS

The unconjugated antibodies showed minimal cross-reactivity with intact immunoglobulins or other proteins. With latex-conjugated antibodies, kappa and lambda FLCs could be measured in normal sera and most normal urine samples. Patients with multiple myeloma had increased concentrations of the relevant serum FLC, whereas both FLCs were increased in the sera of patients with systemic lupus erythematosus.

CONCLUSIONS

We developed sensitive, automated immunoassays for kappa and lambda FLC measurements in serum and urine that should facilitate the assessment of patients with light chain abnormalities.

摘要

背景

本周氏蛋白或单克隆免疫球蛋白κ和λ游离轻链(FLC)是识别和监测许多B细胞肿瘤患者的重要标志物。检测尿液和血清中FLC的自动化免疫测定具有相当大的临床潜力。

方法

通过用纯κ和λ分子免疫制备对FLC特异的绵羊抗体,然后用全免疫球蛋白进行广泛吸附。将抗体偶联到乳胶颗粒上,并用于在贝克曼IMMAGE蛋白质分析仪上检测κ和λFLC。

结果

未偶联的抗体与完整免疫球蛋白或其他蛋白质的交叉反应性最小。使用乳胶偶联抗体,可以在正常血清和大多数正常尿液样本中检测κ和λFLC。多发性骨髓瘤患者相关血清FLC浓度升高,而系统性红斑狼疮患者血清中两种FLC均升高。

结论

我们开发了用于血清和尿液中κ和λFLC测量的灵敏、自动化免疫测定方法,这应有助于评估有轻链异常的患者。

相似文献

1
Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.用于血清和尿液中游离免疫球蛋白轻链的高灵敏度自动化免疫测定法。
Clin Chem. 2001 Apr;47(4):673-80.
2
Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.游离κ和游离λ免疫球蛋白轻链的血清参考区间及诊断范围:检测单克隆轻链的相对敏感性
Clin Chem. 2002 Sep;48(9):1437-44.
3
Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.开发一种使用单克隆抗体的高灵敏度多重分析检测方法,用于同时测量血清和尿液中的kappa 和 lambda 免疫球蛋白游离轻链。
J Immunol Methods. 2013 May 31;391(1-2):1-13. doi: 10.1016/j.jim.2013.01.014. Epub 2013 Feb 4.
4
Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.血清和尿游离轻链的κ与λ(κ:λ)比值差异。
Clin Exp Immunol. 1998 Feb;111(2):457-62. doi: 10.1046/j.1365-2249.1998.00487.x.
5
Polyclonal free light chain of Ig may interfere with interpretation of monoclonal free light chain κ/λ ratio.免疫球蛋白的多克隆游离轻链可能会干扰单克隆游离轻链κ/λ比值的解读。
Ann Clin Lab Sci. 2010 Fall;40(4):348-53.
6
Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.人血清中κ和λ轻链单克隆蛋白的检测:自动免疫分析与免疫固定电泳法
Clin Vaccine Immunol. 2006 Feb;13(2):277-80. doi: 10.1128/CVI.13.2.277-280.2006.
7
Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios.通过比浊法测量个体免疫球蛋白κ/λ比值评估单克隆丙种球蛋白病。
Clin Chem. 2009 Sep;55(9):1646-55. doi: 10.1373/clinchem.2009.123828. Epub 2009 Jul 17.
8
Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis.新型基于单克隆抗体的散射比浊法检测游离轻链 κ 和 λ 与基于多克隆抗体的检测方法和免疫固定电泳的临床比较。
Clin Chem Lab Med. 2011 Nov 23;50(3):489-95. doi: 10.1515/CCLM.2011.793.
9
Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies.血清游离轻链:用于单克隆丙种球蛋白病筛查的尿本-周蛋白检测的替代方法。
Clin Chem. 2006 Sep;52(9):1743-8. doi: 10.1373/clinchem.2006.069104. Epub 2006 Jul 20.
10
Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.游离轻链浓度作为多发性骨髓瘤肿瘤标志物的临床应用价值
Ann Hematol. 2005 Sep;84(9):588-93. doi: 10.1007/s00277-005-1047-z. Epub 2005 May 10.

引用本文的文献

1
B Cell-Derived and Non-B Cell-Derived Free Light Chains: From Generation to Biological and Pathophysiological Roles.B细胞衍生和非B细胞衍生的游离轻链:从产生到生物学及病理生理学作用
Int J Mol Sci. 2025 Aug 6;26(15):7607. doi: 10.3390/ijms26157607.
2
Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresis.血清游离轻链检测在可通过电泳检测到单克隆蛋白的多发性骨髓瘤缓解和病情进展评估中的价值。
Blood Cancer J. 2025 Aug 7;15(1):133. doi: 10.1038/s41408-025-01340-7.
3
Performance and comparison of FLCCheck: a novel serum free light chain assay for the Auxiliary Diagnosis of Multiple Myeloma.
FLCCheck的性能与比较:一种用于多发性骨髓瘤辅助诊断的新型血清游离轻链检测方法
Eur J Med Res. 2025 Aug 4;30(1):706. doi: 10.1186/s40001-025-02984-8.
4
Clinical and immunological biomarkers in hypereosinophilic syndrome: the second step after diagnostic algorithms.高嗜酸性粒细胞综合征的临床和免疫学生物标志物:诊断算法后的第二步。
Front Med (Lausanne). 2025 Jul 2;12:1600728. doi: 10.3389/fmed.2025.1600728. eCollection 2025.
5
Heterohybridomas producing human immunoglobulin light chains using CD138-selected bone marrow cells.使用CD138筛选的骨髓细胞产生人免疫球蛋白轻链的异种杂交瘤。
Biochem Biophys Rep. 2025 Apr 23;42:102017. doi: 10.1016/j.bbrep.2025.102017. eCollection 2025 Jun.
6
Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance: A Review.意义未明的单克隆丙种球蛋白病的诊断与管理:综述
JAMA Intern Med. 2025 Apr 1;185(4):450-456. doi: 10.1001/jamainternmed.2024.8124.
7
Diagnostic and Therapeutic Aspects of Monoclonal Gammopathies of Renal Significance (MGRS): An Update.具有肾脏意义的单克隆丙种球蛋白病(MGRS)的诊断与治疗进展:最新综述
Diagnostics (Basel). 2024 Dec 23;14(24):2892. doi: 10.3390/diagnostics14242892.
8
Kappa index for multiple sclerosis diagnosis: an accurate biomarker of intrathecal synthesis.用于多发性硬化症诊断的kappa指数:鞘内合成的准确生物标志物。
J Neurol. 2024 Dec 12;272(1):30. doi: 10.1007/s00415-024-12826-y.
9
A Comparative Analysis of Freelite and N Latex FLC Assay for the sFLC Measurements in Suspected Patients of Monoclonal Gammopathy.用于疑似单克隆丙种球蛋白病患者血清游离轻链(sFLC)测量的Freelite和N乳胶FLC检测方法的比较分析
Indian J Hematol Blood Transfus. 2024 Oct;40(4):694-700. doi: 10.1007/s12288-024-01747-5. Epub 2024 Apr 24.
10
Navigating the clinical landscape: Update on the diagnostic and prognostic biomarkers in multiple myeloma.在临床环境中前行:多发性骨髓瘤诊断和预后生物标志物的最新进展。
Mol Biol Rep. 2024 Sep 9;51(1):972. doi: 10.1007/s11033-024-09892-w.